Westmount Partners, LLC
- SEC CIK
- 0002051491
- Latest filing
- Jul 7, 2026
PSTX holding history
Poseida Therapeutics, Inc. in every 13F filed by Westmount Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PSTX overviewAll 13F holders of PSTXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −11,000−100.0% | Sold out | Holders |
| Q4 2024 | 11,000 | $105.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 11,000 | $31.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 11,000 | $33.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 11,000 | $35.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 11,000 | $37.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 11,000 | $26.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 11,000 | $19.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 11,000 | $33.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 11,000 | $58.3K | <0.1% | – | No prior filing | Holders |